These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35575750)

  • 1. A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification.
    Osibogun O; Ogunmoroti O; Kolade OB; Hays AG; Okunrintemi V; Minhas AS; Gulati M; Michos ED
    J Womens Health (Larchmt); 2022 Jun; 31(6):762-771. PubMed ID: 35575750
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study.
    Calderon-Margalit R; Siscovick D; Merkin SS; Wang E; Daviglus ML; Schreiner PJ; Sternfeld B; Williams OD; Lewis CE; Azziz R; Schwartz SM; Wellons MF
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2688-94. PubMed ID: 25359859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
    Talbott EO; Zborowski J; Rager J; Stragand JR
    Vasc Health Risk Manag; 2008; 4(2):453-62. PubMed ID: 18561521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls.
    Snyder ML; Shields KJ; Korytkowski MT; Sutton-Tyrrell K; Talbott EO
    Gynecol Endocrinol; 2014 Jul; 30(7):511-5. PubMed ID: 24592986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
    Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.
    Talbott EO; Zborowski JV; Rager JR; Boudreaux MY; Edmundowicz DA; Guzick DS
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5454-61. PubMed ID: 15531497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.
    Christian RC; Dumesic DA; Behrenbeck T; Oberg AL; Sheedy PF; Fitzpatrick LA
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2562-8. PubMed ID: 12788855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
    Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
    Elife; 2023 Aug; 12():. PubMed ID: 37534878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.
    Wu ZH; Tang Y; Niu X; Pu FF; Xiao XY; Kong W
    J Ovarian Res; 2019 Oct; 12(1):94. PubMed ID: 31615559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
    Cooney LG; Lee I; Sammel MD; Dokras A
    Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study.
    Mahboobifard F; Rahmati M; Niknam A; Rojhani E; Momenan AA; Azizi F; Ramezani Tehrani F
    Arch Med Res; 2022 Apr; 53(3):312-322. PubMed ID: 34823887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis.
    Lo ACQ; Lo CCW; Oliver-Williams C
    Eur Heart J Open; 2023 Jul; 3(4):oead061. PubMed ID: 37404840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.
    Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
    Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.
    Meyer ML; Malek AM; Wild RA; Korytkowski MT; Talbott EO
    Hum Reprod Update; 2012; 18(2):112-26. PubMed ID: 22108382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
    Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
    Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
    Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome.
    Sun D; Wu Y; Ding M; Zhu F
    Angiology; 2022 Aug; 73(7):622-634. PubMed ID: 35258380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.